Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever
about
Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancerPopulation pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry.Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.Management of gram-positive bacterial infections in patients with cancer.Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.Role of Daptomycin on Burn Wound Healing in an Animal Methicillin-Resistant Staphylococcus aureus Infection Model.Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.Rapid Turbidimetric Assay to Determine the Potency of Daptomycin in Lyophilized Powder.Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin.Daptomycin use in neutropenic patients with documented gram-positive infections.Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study designPharmacokinetics of daily daptomycin in critically ill patients undergoing continuous renal replacement therapy.Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.
P2860
Q26825326-C6A571A8-7F02-400E-8850-5ED0D86256F5Q33797950-938C9EDE-F896-4918-8C0D-69FA32746415Q36059234-7D410F1C-017C-4915-BB21-E65D9CCB55FAQ37503363-FE7201BD-4BCA-465A-B8D6-0F8D07571595Q37818164-0AE7E1E7-1F63-4938-BFC1-C964AFE62DAFQ37899198-6551E335-FCB9-489F-AA19-35684F81A26FQ38117578-21C7D870-5DF2-48FD-9215-E4D63E0A6CB6Q38247400-C32390B1-065D-4900-B5D3-985AD44234A7Q38684478-5DDEFA63-2A69-4327-81D0-263ADEBE996DQ38895642-8605E7F6-3677-472C-BBB8-2F56677D740AQ40586250-542399D3-8985-4E4E-B5AB-618EB2A1E25EQ41610683-4531FEE7-76DE-4690-911E-0643CA7AA205Q41960102-27DEB656-34E1-407B-AC20-74D38AE56E07Q42249906-CD51DE40-8080-42B5-B6C5-177C00146DD4Q42544277-5EAFA3AF-EE14-491A-BD65-AB8885911412Q44235973-0A3FA8A1-E314-465A-96CE-1A497F1F6EC7Q47574617-162B3CAB-4F1F-46B0-B4A3-635C3A98BFD8
P2860
Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever
@en
Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever.
@nl
type
label
Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever
@en
Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever.
@nl
prefLabel
Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever
@en
Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever.
@nl
P2093
P2860
P356
P1476
Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever
@en
P2093
Brandon Hayes-Lattin
Joseph S Bubalo
Myrna Y Munar
Richard Maziarz
P2860
P304
P356
10.1128/AAC.00943-08
P407
P577
2008-11-17T00:00:00Z